Stay updated on Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page.

Latest updates to the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check13 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check21 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe webpage has been updated to reflect a new version of the study, now labeled as v2.15.0, and includes the addition of the study's focus on metastatic pancreatic cancer and its collaboration with Bristol-Myers Squibb. The previous version's detailed study description and inclusion criteria have been removed.SummaryDifference48%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
Stay in the know with updates to Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Checkpoint Inhibition+Radiation in Pancreatic/Biliary Cancer Clinical Trial page.